Literature DB >> 7684436

Tumor necrosis factor alpha cooperates with interleukin 3 in the recruitment of a primitive subset of human CD34+ progenitors.

C Caux1, I Durand, I Moreau, V Duvert, S Saeland, J Banchereau.   

Abstract

We have recently demonstrated that tumor necrosis factor alpha (TNF-alpha) potentiates interleukin 3 (IL-3) and granulocyte/macrophage colony-stimulating factor-induced growth of CD34+ hematopoietic progenitor cells (HPC), and favors the generation of dendritic/Langerhans cells. The stimulatory effect of TNF-alpha was detailed in the present study. Thus, CD34+ HPC entering in cycle (S/G2M) after a 48-h pulse with IL-3 expressed the transferrin receptor (TfR), and fluorescence-activated cell sorter-separated TfR+ HPC, but not TfR-HPC, showed a high proliferative response to IL-3. In contrast, TfR-HPC were found to undergo strong proliferation in response to IL-3 + TNF-alpha. Limiting dilution experiments indicated that TNF-alpha increased both the frequency and the average size of clones generated from TfR-HPC as a result of the development of a higher number of large clones. In contrast, TNF-alpha did not enhance the IL-3-dependent proliferation of TfR+ HPC. Preculturing CD34+ HPC for 48 h with TNF-alpha enhanced the subsequent generation of IL-3-dependent colony-forming units. Precultures with TNF-alpha or cultures with suboptimal doses of TNF-alpha allowed the recruitment of cells with both granulocytic and monocytic differentiation potential. Taken together, our results indicate that TNF-alpha recruits a subpopulation of CD34+ HPC hyposensitive to IL-3, with high proliferative capacity and some features of multipotential progenitors, that are likely to be more primitive than those responding to IL-3 alone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684436      PMCID: PMC2191038          DOI: 10.1084/jem.177.6.1815

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.

Authors:  G D Roodman; A Bird; D Hutzler; W Montgomery
Journal:  Exp Hematol       Date:  1987-10       Impact factor: 3.084

2.  Effects of recombinant human interleukin-3 on CD34-enriched normal hematopoietic progenitors and on myeloblastic leukemia cells.

Authors:  S Saeland; C Caux; C Favre; J P Aubry; P Mannoni; M J Pebusque; O Gentilhomme; T Otsuka; T Yokota; N Arai
Journal:  Blood       Date:  1988-11       Impact factor: 22.113

3.  The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.

Authors:  H E Broxmeyer; D E Williams; L Lu; S Cooper; S L Anderson; G S Beyer; R Hoffman; B Y Rubin
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

4.  Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells.

Authors:  C Caux; S Saeland; C Favre; V Duvert; P Mannoni; J Banchereau
Journal:  Blood       Date:  1990-06-15       Impact factor: 22.113

5.  Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow.

Authors:  J Brandt; E F Srour; K van Besien; R A Briddell; R Hoffman
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

6.  Detection of a human CFC with a high proliferative potential.

Authors:  I K McNiece; F M Stewart; D M Deacon; D S Temeles; K M Zsebo; S C Clark; P J Quesenberry
Journal:  Blood       Date:  1989-08-01       Impact factor: 22.113

7.  GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells.

Authors:  C Caux; C Dezutter-Dambuyant; D Schmitt; J Banchereau
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

8.  Tumor necrosis factor exerts dose-dependent effects on erythropoiesis and myelopoiesis in vivo.

Authors:  T R Ulich; J del Castillo; S Yin
Journal:  Exp Hematol       Date:  1990-05       Impact factor: 3.084

9.  Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells.

Authors:  M Murphy; B Perussia; G Trinchieri
Journal:  Exp Hematol       Date:  1988-02       Impact factor: 3.084

10.  Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor beta) in natural and lipopolysaccharide-enhanced radioresistance.

Authors:  R Neta; J J Oppenheim; R D Schreiber; R Chizzonite; G D Ledney; T J MacVittie
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  5 in total

1.  Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors.

Authors:  L S Rusten; E B Smeland; F W Jacobsen; E Lien; W Lesslauer; H Loetscher; C M Dubois; S E Jacobsen
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

2.  CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.

Authors:  C Caux; B Vanbervliet; C Massacrier; C Dezutter-Dambuyant; B de Saint-Vis; C Jacquet; K Yoneda; S Imamura; D Schmitt; J Banchereau
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

3.  Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma.

Authors:  H W Snoeck; S Weekx; A Moulijn; F Lardon; M Lenjou; G Nys; P C Van Ranst; D R Van Bockstaele; Z N Berneman
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

4.  B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.

Authors:  C Caux; B Vanbervliet; C Massacrier; M Azuma; K Okumura; L L Lanier; J Banchereau
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

5.  Proliferating dendritic cell progenitors in human blood.

Authors:  N Romani; S Gruner; D Brang; E Kämpgen; A Lenz; B Trockenbacher; G Konwalinka; P O Fritsch; R M Steinman; G Schuler
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.